Skip to content
Research Article Open access CC BY 4.0

COVID-19 Pandemic: Scoping Review through the Lens of 9-Month-based Knowledge and Brief Snapshots of 10 Cases and Five Family Units, Riyadh, Saudi Arabia

Naseem Akhtar Qureshi, Abdulhameed Abdullah Al- Habeeb

International Neuropsychiatric Disease Journal · pp. 14–47 · Published 7 Nov 2020

10.9734/indj/2020/v14i430135

Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has questioning origin in Wuhan, an industrial city of China. The novel coronavirus 2 (NCV2) was first identified in December 2019, and World Health Organization (WHO) declared the outbreak a global public health emergency on 30 January 2020, officially named it as COVID-19 on February 11 2020, and a pandemic on 11 March 2020. COVID-19 causes physical and mental health problems of variable severity and outcomes among people around the world. Objective: This study has two aims;1) to conduct a scoping review of COVID-19’s epidemiological trend, clinical manifestations, therapeutics, diagnosis, and progress on vaccine development; and 2) to describe a case series of ten consultees’ and conveniently selected five family units’ mental and physical health effects of COVID-19 over the past 9 months, December to August 31, 2020. Methods: We used keywords and Boolean Operators for conducting electronic searches of published literature in three largest databases on COVID-19 and regularly received notifications from COVID-19 resource centers, scientific journals, international and national research and economic institutions, and various websites, which helped to retain 82 articles after iterative screening for this review. In addition, 10 cases and the heads of 5 family units were interviewed virtually for assessing the mental and physical health of all family members affected by COVID-19. Results: COVID-19 pandemic presents with variable clinical manifestations and outcomes attributable to the persons’ immune system, age and gender, physical and mental comorbidities, and adversely affects the biopsychosocial, cultural and economic fabrics of the world population. Basic preventive precautions and nonspecific drug interventions against COVID-19 are relatively effective with inconstant morbidity and mortality, and vaccine development researches (phase I-III) are in progress around the world. All persons in case series, not corona positive except one, presented with mental and physical health problems of wider nature that required integrated treatment interventions while majority of family unit members were less affected mentally or physically by COVID-19 and improved with preventive precautions. Conclusion: COVID-19 is highly virulent disease linked with variable mental health problems, greater morbidity and mortality, severe strains on healthcare organizations and economic downturn around the world. Despite difficult access to services, overall our case series and family members showed good outcome. Information concerning COVID-19 is continuously evolving and, hence, further scoping reviews, randomized clinical trials and surveys concerning its several perspectives are needed in Saudi Arabia and elsewhere in the Gulf countries.

Severe acute respiratory syndrome coronavirus-2 COVID-19 pandemic physical and Mental health prevention strategies medication interventions case series and family units.

References (83)

  1. 1 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [DOI]
  2. 2 Clinical Characteristics of Coronavirus Disease 2019 in China [DOI]
  3. 3 Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China [DOI]
  4. 4 Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia [DOI]
  5. 5 COVID-19: consider cytokine storm syndromes and immunosuppression [DOI]
  6. 6 Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China [DOI]
  7. 7 The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application [DOI]
  8. 8 The socio-economic implications of the coronavirus pandemic (COVID-19): A review [DOI]
  9. 9 Presumed Asymptomatic Carrier Transmission of COVID-19 [DOI]
  10. 10 Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany [DOI]
  11. 11 Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records [DOI]
  12. 12 Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study [DOI]
  13. 13 COVID-19 and mental health: A review of the existing literature [DOI]
  14. 14 Antibody responses to SARS-CoV-2 in patients with COVID-19 [DOI]
  15. 15 Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 [DOI]
  16. 16 Mental health care for medical staff in China during the COVID-19 outbreak [DOI]
  17. 17 Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) [DOI]
  18. 18 Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) [DOI]
  19. 19 Viral load of SARS-CoV-2 in clinical samples [DOI]
  20. 20 Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) [DOI]
  21. 21 Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know [DOI]
  22. 22 Fear of the coronavirus (COVID-19): Predictors in an online study conducted in March 2020 [DOI]
  23. 23 Coronavirus Disease 2019 (COVID-19) and Mental Health for Children and Adolescents [DOI]
  24. 24 Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China [DOI]
  25. 25 A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features [DOI]
  26. 26 Emergence of genomic diversity and recurrent mutations in SARS-CoV-2 [DOI]
  27. 27 Potential association between COVID-19 mortality and health-care resource availability [DOI]
  28. 28 Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals [DOI]
  29. 29 Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China [DOI]
  30. 30 A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period [DOI]
  31. 31 Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study [DOI]
  32. 32 Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain [DOI]
  33. 33 Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China
  34. 34 Evidence based management guideline for the COVID-19 pandemic - Review article [DOI]
  35. 35 The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis [DOI]
  36. 36 Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City [DOI]
  37. 37 SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions [DOI]
  38. 38 Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 [DOI]
  39. 39 Prevalence of self-reported depression and anxiety among pediatric medical staff members during the COVID-19 outbreak in Guiyang, China [DOI]
  40. 40 A real-time dashboard of clinical trials for COVID-19 [DOI]
  41. 41 Randomized Clinical Trials and COVID-19 [DOI]
  42. 42 Pharmacokinetics of Lopinavir/Ritonavir Crushed Versus Whole Tablets in Children [DOI]
  43. 43 Initiation of a new infection control system for the COVID-19 outbreak [DOI]
  44. 44 Psychological preparedness for the COVID-19 pandemic, perspectives from India [DOI]
  45. 45 Economic Effects of Coronavirus Outbreak (COVID-19) on the World Economy [DOI]
  46. 46 Risk Management of COVID-19 by Universities in China [DOI]
  47. 47 Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 [DOI]
  48. 48 An Imperative Need for Research on the Role of Environmental Factors in Transmission of Novel Coronavirus (COVID-19) [DOI]
  49. 49 SARS-CoV-2 specific antibody responses in COVID-19 patients [DOI]
  50. 50 Early Short Course Corticosteroids in Hospitalized Patients with COVID-19 [DOI]
  51. 51 Hyperinflammatory shock in children during COVID-19 pandemic [DOI]
  52. 52 Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic [DOI]
  53. 53 Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)
  54. 54 Clinical Characteristics of Coronavirus Disease 2019 in China [DOI]
  55. 55 Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 [DOI]
  56. 56 Neuropathological Features of Covid-19 [DOI]
  57. 57 Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records [DOI]
  58. 58 Impact of coronavirus syndromes on physical and mental health of health care workers: Systematic review and meta-analysis [DOI]
  59. 59 Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China [DOI]
  60. 60 The Socio-Economic Implications of the Coronavirus Pandemic (COVID-19): A Review [DOI]
  61. 61 Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19 [DOI]
  62. 62 A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model [DOI]
  63. 63 Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China [DOI]
  64. 64 Understanding coronaphobia [DOI]
  65. 65 Centers for Disease Control and Prevention [DOI]
  66. 66 Quest for a COVID-19 Cure by Repurposing Small-Molecule Drugs: Mechanism of Action, Clinical Development, Synthesis at Scale, and Outlook for Supply [DOI]
  67. 67 Effects of Corticosteroid Treatment for Non-Severe COVID-19 Pneumonia: A Propensity Score-Based Analysis [DOI]
  68. 68 Can steroids reverse the severe COVID‐19 induced “cytokine storm”? [DOI]
  69. 69 Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study [DOI]
  70. 70 Management of Thrombotic Complications in COVID-19: An Update [DOI]
  71. 71 High‐dose, short‐term corticosteroids for ARDS caused by COVID ‐19: a case series [DOI]
  72. 72 Development of the COVID-19-Anxiety Questionnaire and first psychometric testing [DOI]
  73. 73 COVID-19: Therapeutics and interventions currently under consideration [DOI]
  74. 74 The Neurocritical Care Society of India (NCSI) and the Indian Society of Neuroanaesthesiology and Critical Care (ISNACC) Joint Position Statement and Advisory on the Practice of Neurocritical Care during the COVID-19 Pandemic [DOI]
  75. 75 Treatment of COVID 19—Repurposing drugs commonly used in dermatology [DOI]
  76. 76 Immunomodulatory Therapeutic Proteins in COVID‐19: Current Clinical Development and Clinical Pharmacology Considerations [DOI]
  77. 77 An Overview of Current Clinical Trials of Agents for the Treatment and Prevention of COVID-19 in the United States [DOI]
  78. 78 Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019 [DOI]
  79. 79 Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China [DOI]
  80. 80 Outbreak of Kawasaki disease in children during COVID-19 pandemic: a prospective observational study in Paris, France [DOI]
  81. 81 544. Severe COVID-19 in Children and Young Adults in the Washington DC Metropolitan Region [DOI]
  82. 82 Descriptive epidemiology of 16,780 hospitalized COVID-19 patients in the United States [DOI]
  83. 83 Corticosteroid Use in Severely Hypoxemic COVID-19 Patients: An Observational Cohort Analysis of Dosing Patterns and Outcomes in the Early Phase of the Pandemic [DOI]

Cited by 3

COVID-19 Pandemic and Mental Health Status of Saudi Citizens Living Abroad

Marwah Ahmed Behisi, Hussain M. Altaweel, Reham F. Gassas · International Journal of Environmental Research and Public Health · 2021

Showing 1 of 3 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

34

Page views

0

PDF downloads

4

Outbound clicks

3

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.